Patent · US Active

Method for diagnosing alzheimer's disease

US9606113B2 · kind B2 · utility

0Cited by

2References

6Claims

0Family size

Assignees

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE · FR
UNIVERSITÉ PARIS CITÉ · FR

Inventors

Myriam Taverna · Sceaux, FR
Romain Verpillot · Paris, FR
Markus Otto · Ulm, DE
Hans Klafki · Birkenfeld, DE

Key dates

Filing date	Sep 17, 2012
Grant date	Mar 28, 2017
Priority date	—
Expiry date	Sep 17, 2032

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/52
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The present invention relates to a method for diagnosing a neurodegenerative disease in a subject, wherein the level of each of at least two catecholamines is measured in a sample of biological fluid from said subject.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.